Walgreens Boots Alliance, Inc. (LON:0LSZ)
London
· Delayed Price · Currency is GBP · Price in USD | Market Cap | 7.08B |
| Revenue (ttm) | 120.74B |
| Net Income (ttm) | -4.59B |
| Shares Out | n/a |
| EPS (ttm) | -5.32 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | 0.59 (5.32%) |
| Ex-Dividend Date | Nov 18, 2024 |
| Volume | 3,540 |
| Average Volume | 15,122 |
| Open | 10.97 |
| Previous Close | 10.99 |
| Day's Range | 10.96 - 11.02 |
| 52-Week Range | 10.79 - 36.55 |
| Beta | 0.64 |
| RSI | 51.14 |
| Earnings Date | Jun 25, 2025 |
About Walgreens Boots Alliance
Walgreens Boots Alliance, Inc. operates as a healthcare, pharmacy, and retail company in the United States, Germany, the United Kingdom, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise. The International segment offers sale of p... [Read more]
Financial Performance
In 2024, Walgreens Boots Alliance's revenue was $147.66 billion, an increase of 6.17% compared to the previous year's $139.08 billion. Losses were -$8.64 billion, 180.4% more than in 2023.
Financial numbers in USD Financial StatementsNews
Walgreens Encourages Safe Drug Disposal on National Drug Take Back Day Saturday, April 26, 2025
DEERFIELD, Ill.--(BUSINESS WIRE)--Walgreens is calling on the public to help in the fight against prescription drug abuse by participating in National Prescription Drug Take Back Day on Saturday, Apri...
Walgreens Debuts PharmStart to Strengthen the Tech to Pharmacist Pipeline
DEERFIELD, Ill.--(BUSINESS WIRE)--Walgreens, the nation's largest independent community pharmacy provider, has teamed up with Guild, the leading talent development company, to launch PharmStart, a fir...
Walgreens agrees to pay US up to $350m for illegally filling opioid prescriptions
Drugstore chain settles with DoJ over claims it dispensed millions of unlawful prescriptions for more than a decade
Walgreens to pay up to $350M for filling illegal opioid prescriptions, Justice Department says
Walgreens has agreed to pay up to $350 million to resolve claims that the company illegally filled millions of invalid prescriptions for opioids.
Walgreens (WBA) Agrees to $3.5 Billion Settlement Over Opioid Prescriptions
Walgreens (WBA) Agrees to $3.5 Billion Settlement Over Opioid Prescriptions
Walgreens Encourages Safe Drug Disposal on National Drug Take Back Day Saturday, April 26, 2025
DEERFIELD, Ill.--(BUSINESS WIRE)--Walgreens is calling on the public to help in the fight against prescription drug abuse by participating in National Prescription Drug Take Back Day on Saturday, Apri...
Walgreens settles allegations of filling invalid opioid prescriptions for $300 million, US DOJ says
Walgreens Boots Alliance and its subsidiaries have agreed to pay $300 million to settle U.S. allegations that the pharmacy chain illegally filled millions of invalid prescriptions for opioids and othe...
‘It might be gutted’ – Boots braces for dose of private equity’s bitter medicine
The 176-year-old chemist is preparing for another change of hands. What’s the mood of staff and residents at its home base in Nottinghamshire? ‘We’ve had several rounds of cost-cutting and it could ha...
Walgreens Boots Alliance (WBA) Reaches Settlement with DOJ Over Opioid Dispensing Rules
Walgreens Boots Alliance (WBA) Reaches Settlement with DOJ Over Opioid Dispensing Rules
Walgreens: Acquisition Is The Best-Case Scenario For The Company
Walgreens Boots Alliance faces significant challenges, including rising inflation, heavy competition, and decreasing profitability, making it a Hold if the acquisition by Sycamore goes through. The co...
All 30 Dow Jones Stocks Ranked: Buy, Sell or Hold?
UnitedHealth Group, Nvidia and Amazon.com are Wall Street's top Dow Jones stock to buy now. Some other names might surprise you.
Walgreens Boots Alliance (WBA) Exceeds Earnings and Revenue Expectations
Walgreens Boots Alliance (WBA) Exceeds Earnings and Revenue Expectations
Down 89%, Should You Buy the Dip on Walgreens Boots Alliance?
Investors could profit up to 36% from the stock's current share price, but there are risks.
Walgreens Boots Alliance: Last Change To Buy
US Stocks Futures Trade Mixed Ahead Of Opening Bell: 'Preserve Capital In Conditions Of High Uncertainty,' Says Expert
U.S. stock futures were volatile on Wednesday after the equities reversed gains on Tuesday following President Donald Trump ‘s 104% tariff on China. Futures of major benchmark indices were mixed in pr...
Decoding Walgreens Boots Alliance Inc (WBA): A Strategic SWOT Insight
Decoding Walgreens Boots Alliance Inc (WBA): A Strategic SWOT Insight
WBA stock price: Walgreens beats on revenue in one of its last earnings reports as a public company
Shares in Walgreens Boots Alliance (Nasdaq: WBA) are trading slightly higher this morning after the company reported its Q2 2025 earnings. The results, which beat on earnings and revenue, are notable ...
Walgreens Continues Turnaround Efforts Ahead of Planned Acquisition by Private Equity Firm
Walgreens Boots Alliance (WBA) saw its second-quarter fiscal 2025 sales increase and its operating loss drop as it continues its turnaround plan and prepares to be acquired. The retail pharmacy compan...
Measuring WBA Merger, HUM "Bonds Play," CVS & UNH Options Trades
Spencer Hakimian believes the healthcare sector will withstand the tariff storm well compared to other industries. On specific stocks, he doesn't expect much movement from Walgreens (WBA) after its to...
Crude Oil Gains 1%; Walgreens Posts Upbeat Earnings
U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining more than 2% on Tuesday. The Dow traded up 2.48% to 38,907.32 while the NASDAQ climbed 2.43% to 15,982.51. The S&P 5...
Crude Oil Gains 1%; Walgreens Posts Upbeat Earnings
U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining more than 2% on Tuesday.
Walgreens Boots Alliance Q2 Profit Falls 47.5%, Suspends Guidance On Pending Private Equity Deal
Walgreens Boots Alliance Inc (NASDAQ: WBA) on Tuesday reported second-quarter sales of $38.59 billion, up 4.1% year over year (+4.7% on constant currency), beating the consensus of $38 billion , refle...
4 stocks to watch on Tuesday: WBA, TLRY, MRVL and LLY
Walgreens turnaround still in its early stages, says CEO, as buyout looms
Walgreens Boots Alliance Inc. shares are up 1.2% in premarket trades after the drugstore chain reported better-than-expected second-quarter revenue and adjusted earnings, boosted by an improvement in ...
Walgreens tops estimates as drugstore chain cuts costs, prepares to go private
CNBC's Becky Quick reports on the company's quarterly earnings results.